115 related articles for article (PubMed ID: 34761620)
1. DDX46 accelerates the proliferation of glioblastoma by activating the MAPK-p38 signaling.
Ma J; Gao Z; Liu X
J BUON; 2021; 26(5):2084-2089. PubMed ID: 34761620
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
Chen L; Xu M; Zhong W; Hu Y; Wang G
Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
[TBL] [Abstract][Full Text] [Related]
4. DDX46 silencing inhibits cell proliferation by activating apoptosis and autophagy in cutaneous squamous cell carcinoma.
Lin Q; Jin HJ; Zhang D; Gao L
Mol Med Rep; 2020 Nov; 22(5):4236-4242. PubMed ID: 33000271
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral DDX46 knockdown inhibits growth and induces apoptosis in human colorectal cancer cells.
Li M; Ma Y; Huang P; Du A; Yang X; Zhang S; Xing C; Liu F; Cao J
Gene; 2015 Apr; 560(2):237-44. PubMed ID: 25680556
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells.
Jiang F; Zhang D; Li G; Wang X
Oncol Res; 2017 Mar; 25(3):417-425. PubMed ID: 27697093
[TBL] [Abstract][Full Text] [Related]
7. YY1-Activated Long Noncoding RNA SNHG5 Promotes Glioblastoma Cell Proliferation Through p38/MAPK Signaling Pathway.
Chen L; Gong X; Huang M
Cancer Biother Radiopharm; 2019 Nov; 34(9):589-596. PubMed ID: 31657621
[No Abstract] [Full Text] [Related]
8. The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target.
Ma Z; Song J; Hua Y; Wang Y; Cao W; Wang H; Hou L
Cell Biol Int; 2023 Jan; 47(1):283-291. PubMed ID: 36200534
[TBL] [Abstract][Full Text] [Related]
9. The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells.
Gurgis FM; Yeung YT; Tang MX; Heng B; Buckland M; Ammit AJ; Haapasalo J; Haapasalo H; Guillemin GJ; Grewal T; Munoz L
Oncogene; 2015 May; 34(22):2934-42. PubMed ID: 25088200
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
11. Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant Progression.
Chen X; Hao A; Li X; Ye K; Zhao C; Yang H; Ma H; Hu L; Zhao Z; Hu L; Ye F; Sun Q; Zhang H; Wang H; Yao X; Fang Z
Theranostics; 2020; 10(3):998-1015. PubMed ID: 31938047
[No Abstract] [Full Text] [Related]
12. BIRB796, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells.
Zhao L; Wang Y; Xu Y; Sun Q; Liu H; Chen Q; Liu B
ACS Omega; 2021 May; 6(17):11466-11473. PubMed ID: 34056302
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-520b affects the proliferation of human glioblastoma cells by directly targeting cyclin D1.
Liu X; Wang F; Tian L; Wang T; Zhang W; Li B; Bai YA
Tumour Biol; 2016 Jun; 37(6):7921-8. PubMed ID: 26700671
[TBL] [Abstract][Full Text] [Related]
14. RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway.
Xu Y; Sun Q; Yuan F; Dong H; Zhang H; Geng R; Qi Y; Xiong X; Chen Q; Liu B
J Exp Clin Cancer Res; 2020 Aug; 39(1):174. PubMed ID: 32867814
[TBL] [Abstract][Full Text] [Related]
15. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.
Johannessen TC; Prestegarden L; Grudic A; Hegi ME; Tysnes BB; Bjerkvig R
Neuro Oncol; 2013 Mar; 15(3):269-78. PubMed ID: 23258843
[TBL] [Abstract][Full Text] [Related]
16. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract][Full Text] [Related]
17. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma.
Yang P; Kang W; Pan Y; Zhao X; Duan L
Cancer Manag Res; 2019; 11():8167-8179. PubMed ID: 31564976
[TBL] [Abstract][Full Text] [Related]
19. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
[TBL] [Abstract][Full Text] [Related]
20. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.
Yeung YT; Bryce NS; Adams S; Braidy N; Konayagi M; McDonald KL; Teo C; Guillemin GJ; Grewal T; Munoz L
J Neurooncol; 2012 Aug; 109(1):35-44. PubMed ID: 22528800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
